Two prominent actions of centrally administered neuropeptide Y (NPY) are to reduce experimental anxiety and to increase food intake. Agonist administration studies suggest the former effect to be mediated by NPY-Y1 receptors in the amygdala, while the receptor specificity of the latter action is not entirely understood. Antisense inhibition of Y1 receptor expression has confirmed an anxiolytic action of endogenous NPY, but has not been used to examine its anatomical mediation, or to address whether Y1 receptors are involved in the feeding effects of NPY. In the present study, rats were antisense-treated in a manner previously demonstrated to reduce Y1 receptor density. When preceded by intraventricular administration of an inactive oligonucleotide, bilateral NPY administration in the amygdala was anxiolytic in the elevated plus-maze model. Intraventricular antisense administration, on the other hand, blocked this action of NPY, providing further support for mediation of NPY-induced anxiolysis by Y1 receptors in amygdala. Cumulative food intake was paradoxically increased by antisense treatment, suggesting that NPY-induced feeding may not be mediated by Y1 receptors. Locomotor activity or habituation to novelty were not affected by antisense treatment, suggesting its actions on experimental anxiety and feeding to be behaviorally specific. A heterogeneity of NPY receptors mediating anxiolysis and feeding may prove beneficial for drug development efforts.
Regulatory Peptides – Elsevier
Published: Oct 20, 1995
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera